Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Marjanu Hikmah, Baba, Abdul Aziz, Husin, Azlan, Abdullah, Abu Dzarr, Hassan, Rosline, Sim, Goh Ai, Wahid, S. Fadilah Abdul, Ankathil, Ravindran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555211/
https://www.ncbi.nlm.nih.gov/pubmed/23355941
http://dx.doi.org/10.4081/hr.2012.e23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555211/
https://www.ncbi.nlm.nih.gov/pubmed/23355941
http://dx.doi.org/10.4081/hr.2012.e23

Ejemplares similares